Literature DB >> 18621024

Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic transport of NF-kappaB.

Nozomi Takahashi1, Jeroen W J van Kilsdonk, Benedikt Ostendorf, Ruben Smeets, Sophia W M Bruggeman, Angel Alonso, Fons van de Loo, Matthias Schneider, Wim B van den Berg, Guido W M Swart.   

Abstract

Nucleoporin 88 kDa (Nup88) is a tumor marker, overexpressed in various types of cancer. In Drosophila Nup88 (mbo) was reported to selectively mediate the nucleocytoplasmic transport of NF-kappaB, an ubiquitous transcription factor involved in immune responses, apoptosis, and cancer. We addressed the function of Nup88 in mammalian cells. Selective depletion of Nup88 by small interfering RNA (siRNA) inhibited NF-kappaB-dependent reporter gene activation and the nuclear translocation of NF-kappaB without affecting the upstream activation pathway in NIH3T3 cells. In contrast, nuclear translocation of glucocorticoid receptor was not reduced by the depletion of Nup88. In metastatic melanoma cells overexpressing Nup88, constitutive activation of NF-kappaB was found both in nucleus and cytoplasm. Nup88 depletion in these cells reduced TNF-induced nuclear accumulation of NF-kappaB subunits. We conclude that Nup88 regulates the activity of NF-kappaB at the level of nucleocytoplasmic transport. Overexpression of Nup88 in tumor cells may, thus be involved in the constitutive NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621024     DOI: 10.1016/j.bbrc.2008.06.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Nucleoporin genes in human diseases.

Authors:  Valeria Nofrini; Danika Di Giacomo; Cristina Mecucci
Journal:  Eur J Hum Genet       Date:  2016-04-13       Impact factor: 4.246

Review 2.  New targets for the antitumor activity of gambogic acid in hematologic malignancies.

Authors:  Li-jing Yang; Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

3.  Nucleoporin-Regulated MAP Kinase Signaling in Immunity to a Necrotrophic Fungal Pathogen.

Authors:  Bianca Genenncher; Lennart Wirthmueller; Charlotte Roth; Melanie Klenke; Liang Ma; Amir Sharon; Marcel Wiermer
Journal:  Plant Physiol       Date:  2016-09-02       Impact factor: 8.340

4.  Nucleoporin MOS7/Nup88 contributes to plant immunity and nuclear accumulation of defense regulators.

Authors:  Marcel Wiermer; Hugo Germain; Yu Ti Cheng; Ana V García; Jane E Parker; Xin Li
Journal:  Nucleus       Date:  2010-03-30       Impact factor: 4.197

Review 5.  Role of the nuclear envelope in genome organization and gene expression.

Authors:  David W Van de Vosse; Yakun Wan; Richard W Wozniak; John D Aitchison
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011 Mar-Apr

6.  Nuclear pore complex component MOS7/Nup88 is required for innate immunity and nuclear accumulation of defense regulators in Arabidopsis.

Authors:  Yu Ti Cheng; Hugo Germain; Marcel Wiermer; Dongling Bi; Fang Xu; Ana V García; Lennart Wirthmueller; Charles Després; Jane E Parker; Yuelin Zhang; Xin Li
Journal:  Plant Cell       Date:  2009-08-21       Impact factor: 11.277

Review 7.  The nuclear envelope environment and its cancer connections.

Authors:  Kin-Hoe Chow; Rachel E Factor; Katharine S Ullman
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

Review 8.  Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion.

Authors:  Adhiraj Roy; Gopeshwar Narayan
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-25       Impact factor: 4.553

9.  Regulation of signal transduction by spatial parameters: a case in NF-κB oscillation.

Authors:  Kazuhisa Ichikawa; Daisuke Ohshima; Hiroshi Sagara
Journal:  IET Syst Biol       Date:  2015-04       Impact factor: 1.615

10.  Nucleocytoplasmic transport blockage by SV40 peptide-modified gold nanoparticles induces cellular autophagy.

Authors:  Tsung-Lin Tsai; Chia-Cheng Hou; Hao-Chen Wang; Zih-Syuan Yang; Chen-Sheng Yeh; Dar-Bin Shieh; Wu-Chou Su
Journal:  Int J Nanomedicine       Date:  2012-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.